Sold @ 33centsBought back @ 26 centsThere was bound to be a small retrace with the latest announcement, but one has to think longtermDYORRaving1
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential